Picture of International Biotechnology Trust logo

IBT International Biotechnology Trust News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsBalancedSmall Cap

RCS - Intnl. Biotechnology - Virtual Outlook Presentation

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260206:nRSF1005Sa&default-theme=true

RNS Number : 1005S  Intl. Biotechnology Trust PLC  06 February 2026

6 February 2026

 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC ("IBT")

Virtual Outlook Presentation

 

IBT is pleased to announce that portfolio managers Ailsa Craig and Marek
Poszepczynski will be holding a live presentation on the outlook for the
biotechnology sector in 2026, to be held virtually at 09:00 on Tuesday 10
February 2026.

The presentation is open to all audiences. Questions can be submitted to the
portfolio managers throughout the event.

Please register for the session by the following
link: https://www.schroders.events/IBT26 (https://www.schroders.events/IBT26)
.

 

ENDS

 

Enquiries:

 

 Schroder Investment Management Limited

 Charlotte Banks (Press)                                                      020 7658 6000

 Kirsty Preston

 Natalia De Sousa (Company Secretary)                                         020 7658 6000

 Kaso Legg Communications (Financial PR)                                      IBT@KL-communications.com

 Charles Gorman

 Henry Taylor

 Effie Aye Maung Hider

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUPURUPUPQGPQ



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on International Biotechnology Trust

See all news